162 related articles for article (PubMed ID: 12202906)
1. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
Gillies SD; Lan Y; Brunkhorst B; Wong WK; Li Y; Lo KM
Cancer Immunol Immunother; 2002 Oct; 51(8):449-60. PubMed ID: 12202906
[TBL] [Abstract][Full Text] [Related]
2. Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors.
Helguera G; Rodríguez JA; Penichet ML
Mol Cancer Ther; 2006 Apr; 5(4):1029-40. PubMed ID: 16648575
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a dual cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM expressing tumor cells.
Schanzer JM; Fichtner I; Baeuerle PA; Kufer P
J Immunother; 2006; 29(5):477-88. PubMed ID: 16971804
[TBL] [Abstract][Full Text] [Related]
4. Antibody-cytokine fusion proteins for the therapy of cancer.
Penichet ML; Morrison SL
J Immunol Methods; 2001 Feb; 248(1-2):91-101. PubMed ID: 11223071
[TBL] [Abstract][Full Text] [Related]
5. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
[TBL] [Abstract][Full Text] [Related]
6. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer.
Dela Cruz JS; Huang TH; Penichet ML; Morrison SL
Clin Exp Med; 2004 Oct; 4(2):57-64. PubMed ID: 15672942
[TBL] [Abstract][Full Text] [Related]
7. Antibody-cytokine fusion proteins for the therapy of cancer.
Helguera G; Penichet ML
Methods Mol Med; 2005; 109():347-74. PubMed ID: 15585931
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice.
Xiang R; Silletti S; Lode HN; Dolman CS; Ruehlmann JM; Niethammer AG; Pertl U; Gillies SD; Primus FJ; Reisfeld RA
Clin Cancer Res; 2001 Mar; 7(3 Suppl):856s-864s. PubMed ID: 11300483
[TBL] [Abstract][Full Text] [Related]
9. Bacillus Calmette-Guérin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro.
Fujimoto T; O'Donnell MA; Szilvasi A; Yang H; Duda RB
Cancer Immunol Immunother; 1996 Jun; 42(5):280-4. PubMed ID: 8706049
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.
Nishisaka N; Maini A; Kinoshita Y; Yasumoto R; Kishimoto T; Jones RF; Morse P; Hillman GG; Wang CY; Haas GP
J Immunother; 1999 Jul; 22(4):308-14. PubMed ID: 10404432
[TBL] [Abstract][Full Text] [Related]
11. A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cells.
Schanzer JM; Baeuerle PA; Dreier T; Kufer P
Cancer Immun; 2006 Feb; 6():4. PubMed ID: 16483188
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors.
Helguera G; Dela Cruz JS; Lowe C; Ng PP; Trinh R; Morrison SL; Penichet ML
Vaccine; 2006 Jan; 24(3):304-16. PubMed ID: 16125282
[TBL] [Abstract][Full Text] [Related]
13. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients.
Parihar R; Nadella P; Lewis A; Jensen R; De Hoff C; Dierksheide JE; VanBuskirk AM; Magro CM; Young DC; Shapiro CL; Carson WE
Clin Cancer Res; 2004 Aug; 10(15):5027-37. PubMed ID: 15297404
[TBL] [Abstract][Full Text] [Related]
15. The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1.
Lees CJ; Apostolopoulos V; Acres B; Ong CS; Popovski V; McKenzie IF
Cancer Immunol Immunother; 2000 Feb; 48(11):644-52. PubMed ID: 10663612
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
[TBL] [Abstract][Full Text] [Related]
17. Idiotype-cytokine fusion proteins as cancer vaccines. Relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor.
Chen TT; Tao MH; Levy R
J Immunol; 1994 Nov; 153(10):4775-87. PubMed ID: 7525715
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
Majumdar AS; Zolotorev A; Samuel S; Tran K; Vertin B; Hall-Meier M; Antoni BA; Adeline E; Philip M; Philip R
Cancer Gene Ther; 2000 Jul; 7(7):1086-99. PubMed ID: 10917212
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Jagged-1 on the cytokine expression of murine myeloid-derived dendritic cells].
Fang ZY; Xing FY; Guo ZF; Chen L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):100-3. PubMed ID: 19174003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
